
Opinion|Videos|September 30, 2023
The Evolution of the Treatment Landscape for Follicular Lymphoma
Expert oncologists discuss the evolving treatment landscape for follicular lymphoma and highlight key advances that have contributed to improved treatment options.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer
2
FDA Approves Subcutaneous Isatuximab in Multiple Myeloma
3
EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process
4
HARMONi-6: Evaluating the Safety and Generalizability of Ivonescimab in NSCLC
5






![“[Epcoritamab/R2] is a good option for [patients] at first relapse or even further, even if they are very high risk,” said Benoit Tessoulin, MD, PhD.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d4c175d2fd9b443716f5ad06bfae7bc796a1795a-1200x1200.jpg?w=350&fit=crop&auto=format)










































































